Randomized, double-blind phase II study of the matrix metalloprotease (MMP) inhibitor, AG3340 (Prinomastat™) in patients with myelodysplastic syndrome (MDS).

被引：0
|
作者：
List, AF
Kurtin, SE
Callander, N
Anderson, JE
Foran, JM
Rabinowitz, I
Glinsmann-Gibson, BJ
Bellamy, WT
Bennett, JM
Collier, M
Mazabel, E
机构：
[1] Univ Arizona, Coll Med, Arizona Canc Ctr, Tucson, AZ 85724 USA
[2] Univ Texas, Hlth Sci Ctr, Canc Res & Treatment Ctr, San Antonio, TX USA
[3] Univ Nebraska, Med Ctr, Eppley Inst Res Canc, Omaha, NE USA
[4] Univ New Mexico, Ctr Canc, Div Hematol Oncol, Albuquerque, NM 87131 USA
[5] Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY 14627 USA
[6] Pfizer Pharmaceut Inc, La Jolla, CA USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3119
引用
收藏
页码：789A / 789A
页数：1
相关论文
共 50 条
  • [41] Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: A report from the 11715 study group
    McDermott, David F.
    Sosman, Jeffrey A.
    Gonzalez, Rene
    Hodi, F. Stephen
    Linette, Gerald P.
    Richards, Jon
    Jakub, W.
    Beeram, Muralidhar
    Tarantolo, Stefano
    Agarwala, Sanjiv
    Frenette, Gary
    Puzanov, Igor
    Cranmer, Lee
    Lewis, Karl
    Kirkwood, John
    White, J. Michael
    Xia, Chenghua
    Patel, Kiran
    Hersh, Evan
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (13) : 2178 - 2185
  • [42] A double-blind, randomized, multicenter, dose-ranging phase II study of the misoprostol vaginal insert
    Powers, Barbara
    Parker, Lamar
    Miller, Hugh
    Wing, Deborah A.
    Rayburn, William
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 : S48 - S48
  • [43] Phase II, randomized, double-blind study of two dose levels of arzoxifene in patients with locally advanced or metastatic breast cancer
    Buzdar, A
    O'Shaughnessy, JA
    Booser, DJ
    Pippen, JE
    Jones, SE
    Munster, PN
    Peterson, P
    Melemed, AS
    Winer, E
    Hudis, C
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (06) : 1007 - 1014
  • [44] Evaluation of vandetanib in patients with inoperable hepatocellular carcinoma (HCC): a randomized, double-blind, parallel group, multicentre, Phase II study
    Hsu, C.
    Yang, T. S.
    Huo, T. L.
    Hsieh, R. K.
    Hwang, W. S.
    Hsieh, T. Y.
    Huang, W. T.
    Chao, Y.
    Meng, R.
    Cheng, A. L.
    EJC SUPPLEMENTS, 2009, 7 (02): : 367 - 367
  • [45] Determining an Optimal Dose of Linaclotide in Use in Japanese Patients With Irritable Bowel Syndrome With Constipation: A Phase II Randomized, Double-Blind, Placebo-Controlled Study
    Fukudo, Shin
    Nakajima, Atsushi
    Fujiyama, Yoshihide
    Kosako, Masanori
    Nakagawa, Ayako
    Akiho, Hiraku
    Nakashima, Yoshihiro
    Johnston, Jeffrey
    Miwa, Hiroto
    GASTROENTEROLOGY, 2016, 150 (04) : S735 - S735
  • [46] Determining an optimal dose of linaclotide for use in Japanese patients with irritable bowel syndrome with constipation: A phase II randomized, double-blind, placebo-controlled study
    Fukudo, S.
    Nakajima, A.
    Fujiyama, Y.
    Kosako, M.
    Nakagawa, A.
    Akiho, H.
    Nakashima, Y.
    Johnston, J. M.
    Miwa, H.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 30 (05):
  • [47] Interim Analysis of a Phase II Study of the Glutaminase Inhibitor Telaglenastat (CB-839) in Combination with Azacitidine in Advanced Myelodysplastic Syndrome (MDS)
    Guerra, Veronica A.
    Burger, Jan A.
    Borthakur, Gautam M.
    Jabbour, Elias
    Pemmaraju, Naveen
    Kadia, Tapan M.
    Garcia-Manero, Guillermo
    Kantarjian, Hagop M.
    Konopleva, Marina Y.
    DiNardo, Courtney D.
    BLOOD, 2019, 134
  • [48] A phase II study of mocetinostat, an oral isotype-selective histone deacetylase (HDAC) inhibitor, in combination with 5-azacitidine in patients with myelodysplastic syndrome (MDS)
    Luger, Selina M.
    O'Connell, Casey Lee
    Klimek, Virginia
    Cooper, Maureen A.
    Besa, Emmanuel C.
    Rossetti, James M.
    Reid, Gregory K.
    Humphrey, Rachel
    Martell, Robert E.
    Garcia-Manero, Guillermo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [49] A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma
    Cui, Chuanliang
    Mao, Lili
    Chi, Zhihong
    Si, Lu
    Sheng, Xinan
    Kong, Yan
    Li, Siming
    Lian, Bin
    Gu, Kangsheng
    Tao, Min
    Song, Xin
    Lin, Tongyu
    Ren, Xiubao
    Qin, Shukui
    Guo, Jun
    MOLECULAR THERAPY, 2013, 21 (07) : 1456 - 1463
  • [50] COLORECTAL CANCER, VITAMIN D AND MICROBIOTA: A DOUBLE-BLIND PHASE II RANDOMIZED TRIAL IN COLORECTAL CANCER PATIENTS
    Serrano, Davide
    Bellerba, Federica
    Johansson, Harriet
    Gnagnarella, Patrizia
    Macis, Debora
    Aristarco, Valentina
    Gonzaga, Aliana Guerrieri
    Biffi, Roberto
    Bottiglieri, Luca
    Trovato, Cristina
    Zampino, Maria Giulia
    Gandini, Sara
    ANTICANCER RESEARCH, 2022, 42 (04) : 2194 - 2194
12345